PAVmed CarpX Device Clinical Study

Last updated: April 29, 2020
Sponsor: PAVmed Inc.
Overall Status: Completed

Phase

N/A

Condition

Carpal Tunnel Syndrome

Treatment

N/A

Clinical Study ID

NCT03747510
PAVmed CarpX-01-018
  • Ages > 18
  • All Genders

Study Summary

To study the safety and feasibility of the CarpX device to divide and release the transverse carpal ligament in order to provide relief for Carpal Tunnel Syndrome (CTS).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient is > 18 years old

  • Patient is scheduled to undergo carpal tunnel release surgery

  • Patient has failed to respond to conservative treatment of CTS

  • CTS confirmed by strong clinical signs and positive Nerve Conduction Velocity (NCV)test

  • Patient, or authorized representative, signs a written Informed Consent form toparticipate in the study, prior to any study mandated procedures Patient is willingand able to complete follow-up requirements

Exclusion

Exclusion Criteria:

  • Patient has a prior or current musculoskeletal or neurologic condition that limitsstrength, motion, or sensation in the affected hand that is unrelated to carpal tunnelsyndrome.

  • Patient with stiff wrist, suspected space occupying lesions or other anatomicabnormalities of the forearm, wrist or hand or other concerns related to patientanatomy such as small wrist and/or thin skin

  • Prior invasive treatment of the hand or wrist for disease processes such as DeQuervain's syndrome, arthritic wrist etc. on the intended treatment side

  • Previous trauma/fracture or other anatomic abnormalities of the forearm, wrist or handon the intended treatment side

  • Patient has an ipsilateral injury or other conditions affecting hand function

  • Patient has acute CTS resulting from an injury (e.g., fracture)

  • Patient has had previous CTR surgery on the affected hand

  • Patient has severe chronic median nerve neuropathy shown by the EMG and NCS that showsdenervation of the thenar muscle

  • Active local or systemic infection

  • Known allergy to any device component

  • Known severe allergy to contrast reagent that cannot be managed with premedication

  • Any significant medical condition(s) that would place patient at excessive risk forsurgery such as: known bleeding disorder including thrombocytopenia (platelet count < 80,000), thrombasthenia, hemophilia or Von Willebrand's disease, unstable cardiacdisease, renal failure or uncontrolled diabetes

  • Patient has other medical, social or psychological problem that in the opinion of theinvestigator precludes them from fully participating

  • Women who are pregnant

Study Design

Total Participants: 20
Study Start date:
January 05, 2019
Estimated Completion Date:
December 30, 2019

Study Description

This is a prospective, single center, single arm, study of the CarpX device for treatment of carpel tunnel syndrome. Patients will be followed for up to 30 days post procedure.

Connect with a study center

  • Christchurch Hospital

    Christchurch, 8011
    New Zealand

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.